# Clinical Translation of 18F-Labeled Hydroxyphenethylguanidines

> **NCT02385877** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Michigan** · enrollment: 16 (actual)

## Conditions studied

- Autonomic Peripheral Nervous System Diseases

## Interventions

- **DRUG:** [18F]4F-MHPG
- **DRUG:** [18F]3F-PHPG

## Key facts

- **NCT ID:** NCT02385877
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02385877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02385877, "Clinical Translation of 18F-Labeled Hydroxyphenethylguanidines". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02385877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*